Mehl/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 (Fed. Cir. 1999). · Go Syfert
Mehl/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 (Fed. Cir. 1999). Cases Citing This Book View Copy Cite
“the polla article's failure to mention hair depilation as a goal is similarly irrelevant .... does not dispute on appeal that the laser operating parameters disclosed in the article substantially coincide with those disclosed in the patent”
177 citation events (157 in the last 25 years) across 26 distinct courts.
Strongest positive: Perricone v. Medicis Pharmaceutical Corp. (ctd, 2003-06-16)
Treatment trajectory · 1999 → 2026 · click a year to view as-of
1999 2012 2026
Top citers, strongest first. 50 distinct citers. How cited ↗
examined Cited as authority (verbatim quote) Perricone v. Medicis Pharmaceutical Corp. (2×) also: Cited "see"
D. Conn. · 2003 · signal: see also · quote attribution · 1 verbatim quote · confidence high
inher-ency is not necessarily coterminous with the knowledge of those of ordinary skill in the art. artisans of ordinary skill may not 246 recognize the inherent characteristics or functioning of the prior art.
discussed Cited as authority (quoted) Kahr v. Cole
E.D. Wis. · 2016 · quote attribution · 1 verbatim quote · confidence low
where ... the result is a necessary consequence of what was deliberately intended, it is of no import that the article's authors did not appreciate the results.
examined Cited as authority (quoted) King Pharmaceuticals, Inc. v. Eon Labs, Inc. (3×) also: Cited as authority (rule)
E.D.N.Y · 2009 · quote attribution · 1 verbatim quote · confidence low
inherency is not necessarily coterminous with the knowledge of those of ordinary skill in the art. artisans of ordinary skill may not recognize the inherent characteristics or functioning of the prior art.
discussed Cited as authority (quoted) Cohesive Technologies, Inc. v. Waters Corp. (2×) also: Cited "see, e.g."
Fed. Cir. · 2008 · signal: compare · quote attribution · 1 verbatim quote · confidence low
to anticipate, a single reference must teach every limitation of the claimed invention.
examined Cited as authority (quoted) Bristol-Myers Squibb Co. v. Boehringer Ingelheim Corp. (2×) also: Cited as authority (rule)
D.N.J. · 2000 · signal: see · quote attribution · 1 verbatim quote · confidence high
the polla article's failure to mention hair depilation as a goal is similarly irrelevant .... does not dispute on appeal that the laser operating parameters disclosed in the article substantially coincide with those disclosed in the patent
discussed Cited as authority (rule) Merck Sharp & Dohme Corp. v. Hospira Inc.
D. Del. · 2016 · confidence medium
“The mere fact that a certain thing may result from a given set of circumstances is not sufficient.” MEHL/Biophile, 192 F.3d at 1365 (emphasis in original) (quoting In re Oelrich, 666 F.2d 578, 581 (C.C.P.A. 1981)).
examined Cited as authority (rule) U.S. Water Services, Inc. v. Novozymes A/S (6×)
W.D. Wis. · 2015 · confidence medium
Id. at 1364-65.
discussed Cited as authority (rule) I.E.E. International Electronics & Engineering, S.A. v. TK Holdings Inc.
E.D. Mich. · 2014 · confidence medium
To establish that the asserted claims of the '169 Patent are invalid as anticipated under 35 U.S.C. § 102 , Defendant must point to a single prior art reference or prior invention that “disclose[s] every limitation of the claimed invention, either explicitly or inherently.” MEHL/Biophile International Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.Cir.1999) (internal quotation marks and citation omitted).
discussed Cited as authority (rule) Only the First, Ltd. v. Seiko Epson Corp.
N.D. Ill. · 2011 · confidence medium
The Court cannot accept this argument because “ ‘[i]nherency is not necessarily coterminous with the knowledge of those of ordinary skill in the art.’ ” In re Cruciferous Sprout Litig., 301 F.3d at 1349 (quoting MEHL/Biophile Int'l Corp., 192 F.3d at 1365).
discussed Cited as authority (rule) General Electric Co. v. Sonosite, Inc.
W.D. Wis. · 2009 · confidence medium
“Thus, a prior art reference may anticipate when the claim limitation or limitations not expressly found in that reference are nonetheless inherent in it.” MEHL/Biophile International Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.Cir.1999).
cited Cited as authority (rule) CLEARWATER SYSTEMS CORP. v. Evapco, Inc.
D. Conn. · 2009 · confidence medium
MEHL/Biophile International Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.Cir.1999).
examined Cited as authority (rule) Henrob Ltd. v. Böllhoff Systemtechnick GmbH & Co. (3×) also: Cited "see, e.g."
E.D. Mich. · 2008 · confidence medium
Inherence “may not be established by probabilities or possibilities.” MEHL/Biophile Int’l Corp., 192 F.3d at 1365.
cited Cited as authority (rule) Leggett & Platt, Inc. v. VUTEk, Inc.
Fed. Cir. · 2008 · confidence medium
MEHL/Biophile, 192 F.3d at 1365.
discussed Cited as authority (rule) Perricone v. Medicis Pharmaceutical Corp.
D. Conn. · 2008 · confidence medium
Artisans of ordinary skill may not recognize the inherent characteristics or functioning of the prior art.” Id.; see also Sobering Corp. v. Geneva Pharms., 339 F.3d 1373 , 1377 (Fed.Cir.2003) (rejecting the contention that inherent anticipation requires recognition in the prior art) (citing In re Cruciferous Sprout Litig., 301 F.3d at 1351 ; MEHL/Biophile, 192 F.3d at 1366).
examined Cited as authority (rule) Nicholas v. Perricone, M.D. v. Medicis Pharmaceutical Corporation, Defendant-Cross (4×) also: Cited "see"
Fed. Cir. · 2005 · confidence medium
Artisans of ordinary skill may not recognize the inherent characteristics or functioning of the prior art.” Id.; see also Sobering Corp. v. Geneva Pharms., 339 F.3d 1373 , 1377 (Fed.Cir.2003) (rejecting the contention that inherent anticipation requires recognition in the prior art) (citing In re Cruciferous Sprout Litig., 301 F.3d at 1351 ; MEHL/Biophile, 192 F.3d at 1366).
discussed Cited as authority (rule) Perricone, M.D. v. Medicis Pharmaceutical Corp. (2×) also: Cited "see"
Fed. Cir. · 2005 · confidence medium
“Under the principles of inherency, if the prior art necessarily functions in accordance with, or includes, the claims limitations, it anticipates.” Id. (quoting MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.
examined Cited as authority (rule) Automotive Technologies International v. BMW of North America, Inc. (3×) also: Cited "see", Cited "see, e.g."
E.D. Mich. · 2005 · confidence medium
Inherence “may not be established by probabilities or possibilities.” MEHL/Biophile Int’l Corp., 192 F.3d at 1365.
cited Cited as authority (rule) Kwik Products, Inc. v. National Express, Inc.
S.D.N.Y. · 2005 · confidence medium
MEHL/Biophile, 192 F.3d at 1365.
discussed Cited as authority (rule) Engate, Inc. v. Esquire Deposition Services, L.L.C.
N.D. Ill. · 2004 · confidence medium
The Federal Circuit has explained that “ ‘[u]nder the principles of inherency, if the prior art necessarily functions in accordance with, or includes, the claimed limitations, it anticipates.’” In re Cruciferous Sprout Litigation, 301 F.3d 1343, 1349 (Fed.Cir.2002) (quoting MEHL/Biophile International Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.Cir.1999)).
discussed Cited as authority (rule) Emergency Fuel, LLC v. Pennzoil-Quaker State Co.
D. Maryland · 2003 · confidence medium
All the doctrine requires is that “the prior art necessarily functions in accordance with, or includes, the claimed limitations.” MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.Cir.1999).
cited Cited as authority (rule) Scanner Technologies Corp. v. Icos Vision Systems Corp.
S.D.N.Y. · 2003 · confidence medium
MEHL/Biophile, 192 F.3d at 1365.
discussed Cited as authority (rule) SmithKline Beecham Corp. v. Apotex Corp.
N.D. Ill. · 2003 · confidence medium
The mere fact that a certain thing may result from a given set of circumstances is not sufficient.” MEHL/Biophile Int’l Corp. v. Milgraum, supra, 192 F.3d at 1365 (emphasis in original); see also In re Robertson, 169 F.3d 743, 745 (Fed.Cir.1999); Glaxo Inc. v. Novopharm Ltd., 52 F.3d 1043, 1047-48 (Fed.Cir.1995); Continental Can Co. USA, Inc. v. Monsanto Co., 948 F.2d 1264, 1268-69 (Fed.Cir.1991).
discussed Cited as authority (rule) Roche Diagnostics Corp. v. Bayer Corp. (2×) also: Cited "see, e.g."
S.D. Ind. · 2003 · confidence medium
But, “a prior art reference may anticipate when the claim limitations not expressly found in that reference are nonetheless inherent in it.” MEHL/Biophile Int’l, 192 F.3d at 1365.
discussed Cited as authority (rule) U-Fuel, Inc. (NV) v. Highland Tank & Manufacturing Co.
E.D. Pa. · 2002 · confidence medium
Artisans of ordinary skill may not recognize the inherent characteristics or functioning of the prior art.” MEHL/Biophile, 192 F.3d at 1365; In re Cruciferous, 168 F.Supp.2d at 538 (“It is important to note that a property or result can be inherent in prior art regardless of whether those skilled in the art were previously aware of that property or result.”).
examined Cited as authority (rule) In Re Cruciferous Sprout Litigation (3×) also: Cited "see, e.g."
Fed. Cir. · 2002 · confidence medium
Artisans of ordinary skill may not recognize the inherent characteristics or functioning of the prior art." MEHL/Biophile, 192 F.3d at 1365, 52 USPQ2d at 1305-06; Atlas Powder, 190 F.3d at 1347 , 51 USPQ2d at 1946-47. 18 Brassica does not claim to have invented a new kind of sprout, or a new way of growing or harvesting sprouts.
examined Cited as authority (rule) Brassica Protection Products LLC v. Sunrise Farms (3×) also: Cited "see, e.g."
Fed. Cir. · 2002 · confidence medium
Artisans of. ordinary skill may not recognize the inherent characteristics or functioning of the prior art.” MEHL/Biophile, 192 F.3d at 1365, 52 USPQ2d at 1305-06; Atlas Powder, 190 F.3d at 1347 , 51 USPQ2d at 1946-47.
cited Cited as authority (rule) Schering Corp. v. Geneva Pharmaceuticals, Inc.
D.N.J. · 2002 · confidence medium
MEHL/Biophile International Corp. v. Milgraum, M.D., 192 F.3d 1362, 1365 (Fed.Cir.1999).
cited Cited as authority (rule) 3M Unitek Corp. v. Ormco Co.
C.D. Cal. · 2000 · confidence medium
MEHL/Biophile International Corp. v. Milgraum, 192 F.3d 1362, 1365 (Fed.Cir.1999).
examined Cited as authority (rule) Biacore, AB v. Thermo Bioanalysis Corp. (3×) also: Cited "see"
D. Del. · 1999 · confidence medium
“Occasional results are not inherent.” MEHL/Biophile Int’l Corp., 192 F.3d at 1365.
cited Cited "see" In Re SONG
Fed. Cir. · 2026 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.
discussed Cited "see" Cochlear Bone Anchored v. Oticon Medical Ab
Fed. Cir. · 2020 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.
discussed Cited "see" Malibu Boats, LLC v. Nautique Boat Co. (2×) also: Cited "see, e.g."
E.D. Tenn. · 2015 · signal: see · confidence high
See MEHL, 192 F.3d at 1366 (looking to whether the relevant limitation, “as claimed,” is a natural result flowing from the operation as taught in the prior art); In re Oelrich, 666 F.2d 578, 581 (C.C.P.A. 1981) (“[M]ere recitation of a newly discovered function or property, inherently possessed by things in the prior art, does not distinguish a claim drawn to those things from the prior art.”); see also Bettcher Indus., Inc. v. Bunzl USA, Inc., 661 F.3d 629, 654 (Fed.Cir.2011) (Reyna, J., dissenting) (“Where all structural elements of a claim exist in a prior art product, and that pr…
discussed Cited "see" Jacobs Vehicle Equipment Co. v. Pacific Diesel Brake Co.
D. Conn. · 2011 · signal: see · confidence high
See Mehl/Biophile Int’l Corp. v. Milgraum, 8 F.Supp.2d 434, 444 (D.N.J.1998), aff'd, 192 F.3d 1362 (Fed.Cir.1999); Ciba-Geigy Corp. v. Alza Corp., 864 F.Supp. 429, 438 (D.N.J.1994), aff'd in part, vacated in part, 68 F.3d 487 (Fed.Cir.1995); Procter & Gamble Co. v. Nabisco Brands, Inc., 711 F.Supp. 759, 772 (D.Del.1989).
cited Cited "see" Eli Lilly and Co. v. Actavis Elizabeth LLC
D.N.J. · 2009 · signal: see · confidence high
See MEHL/Biophile Int’l Corp., 192 F.3d at 1365.
cited Cited "see" In Re Tzipori
Fed. Cir. · 2008 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1366 (Fed.Cir.1999).
discussed Cited "see" Honeywell International Inc. v. United States (2×)
Fed. Cl. · 2008 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999) (“Inherency, however, may not be established by probabilities or possibilities.”). ii. “for use in association with a light amplifying passive night vision aid” The Government argues that Task & Griffin III, “Pave Low III Interior Lighting Reconfiguration for Night Lighting and Night Vision Goggle Compatibility,” and several explicit references pertaining to the use of NVGs, together disclose the use of night vision goggles.
discussed Cited "see" Therasense, Inc. v. Becton, Dickinson and Co. (2×)
N.D. Cal. · 2008 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999).
discussed Cited "see" In Re Omeprazole Patent Litigation. Astra Aktiebolag, Aktiebolaget Hassle, Astra Merck Enterprises Inc., Astra Merck Inc., Kbi-E, Inc., Kbi, Inc., and Astrazeneca Lp, Plaintiffs-Cross v. Andrx Pharmaceuticals, Inc., and Genpharm, Inc., Kremers Urban Development Co., and Schwarz Pharma, Inc.
Fed. Cir. · 2007 · signal: see · confidence high
See MEHL/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir. 1999) (to anticipate, a single reference must teach every limitation of the claimed invention; any limitation not explicitly taught must be inherently taught and would be so understood by a person experienced in the field); In re Baxter Travenol Labs., 952 F.2d 388, 390 (Fed.Cir.1991) (the dispositive question is "whether one skilled in the art would reasonably understand or infer" that a reference teaches or discloses all of the elements of the claimed invention); Continental Can Co. v. Monsanto Co., 948 F.2d 1264, 1268…
discussed Cited "see" Aktiebolag v. Andrx Pharmaceuticals, Inc.
Fed. Cir. · 2007 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999) (to anticipate, a single reference must teach every limitation of the claimed invention; any limitation not explicitly taught must be inherently taught and would be so understood by a person experienced in the field); In re Baxter Travenol Labs., 952 F.2d 388, 390 (Fed.Cir.1991) (the dispositive question is “whether one skilled in the art would reasonably understand or infer” that a reference teaches or discloses all of the elements of the claimed invention); Continental Can Co. v. Monsanto Co., 948 F.2d 1264,…
discussed Cited "see" Impax Laboratories, Inc. v. Aventis Pharmaceuticals, Inc. (2×)
Fed. Cir. · 2006 · signal: see · confidence high
See MEHL/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999).
cited Cited "see" Revolution Eyewear, Inc. v. Aspex Eyewear, Inc.
Fed. Cir. · 2006 · signal: see · confidence high
See MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999).
discussed Cited "see" Smithkline Beecham Corp. v. Apotex Corp. (2×)
Fed. Cir. · 2005 · signal: accord · confidence high
In re Oelrich, 666 F.2d 578, 581 (CCPA 1981); accord MEHL/Biophile Int'l Corp., 192 F.3d at 1366; see also Atlas Powder, 190 F.3d at 1349-50 (affirming the district court's finding of inherent anticipation despite a finding that the inherent element could be avoided by taking "extraordinary measures" when practicing the prior art).
discussed Cited "see" Minnesota Mining and Manufacturing Company v. Chemque, Inc. (Formerly Known as Chemque Canada, Ltd.) and Thomas & Betts Corporation, Defendants-Cross (2×)
Fed. Cir. · 2002 · signal: see · confidence high
See MEHL/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 , 1366, 52 USPQ2d 1303, 1306 (Fed.
discussed Cited "see" Sibia Neurosciences, Inc. v. Cadus Pharmaceutical Corporation,defendant-Appellant (2×)
Fed. Cir. · 2000 · signal: see · confidence high
See Mehl/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 , 1367, 52 USPQ2d 1303, 1307 (Fed.
examined Cited "see" Purdue Pharma L.P. v. Boehringer Ingelheim GmbH (3×)
S.D.N.Y. · 2000 · signal: accord · confidence high
See Atlas Powder Co. v. Ireco Inc., 190 F.3d 1342, 1346 (Fed.Cir.1999) (citing Titanium Metals Corp. v. Banner, 778 F.2d 775, 781 (Fed.Cir.1985)). “ ‘To anticipate a claim, a prior art reference must disclose every limitation of the claimed invention, either explicitly or inherently.’ ” Id. (quoting In re Schreiber, 128 F.3d 1473, 1477 (Fed.Cir.1997)); accord MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999).
discussed Cited "see, e.g." PowX Inc. v. Performance Solutions, LLC
S.D.N.Y. · 2024 · signal: see also · confidence low
To disclose the features of the claimed invention, the prior art must “describe every element of the claimed invention, either expressly or inherently, such that a person of ordinary skill in the art could practice the invention without undue experimentation.” Advanced Display Sys., Inc. v. Kent State Univ., 212 F.3d 1272 , 1282 (Fed.Cir.2000); see also MEHL/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.
discussed Cited "see, e.g." Synopsys, Inc. v. Mentor Graphics Corporation (2×)
Fed. Cir. · 2016 · signal: see also · confidence low
See In re Oelrich, 666 F.2d 578, 581 (C.C.P.A.1981); see also MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999) (noting that a “possibility” that under certain circumstances a laser designed for tattoo removal may be pointed at hair follicles “does not legally suffice to show anticipation” of a patent involving laser hair removal).
discussed Cited "see, e.g." Baby Jogger, LLC v. Britax Child Safety, Inc.
E.D. Va. · 2013 · signal: see also · confidence low
See also MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999) (“Under the principles of inherency, if the prior art necessarily functions in accordance with, or includes, the claimed limitations, it anticipates.”).
discussed Cited "see, e.g." Orenshteyn v. International Business Machines, Corp.
S.D.N.Y. · 2013 · signal: see also · confidence low
A patent claim is invalid if it is anticipated by the prior art, that is, “where ‘each and every limitation is found either expressly or inherently in a single prior art reference.’ ” ArcelorMittal France v. AK Steel Corp., 700 F.3d 1314, 1322 (Fed.Cir.2012) (quoting Celeritas Techs., Ltd. v. Rockwell Int’l Corp., 150 F.3d 1354, 1361 (Fed.Cir.1998)); see also MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1365 (Fed.Cir.1999) (“Under the principles of inherency, if the prior art necessarily functions in accordance with, or includes, the claimed limitations, it anticipates.…
discussed Cited "see, e.g." King Pharmaceuticals, Inc. v. Eon Labels, Inc
Fed. Cir. · 2010 · signal: see also · confidence low
In other words, the increase in metaxalone’s bioavailability is the “ ‘natural result’ flowing from the [prior art’s] explicitly explicated limitations.” Eli Lilly & Co. v. Barr Labs., Inc., 251 F.3d 955 , 970 (Fed.Cir.2001) (alterations added); see also MEHL/Biophile Int’l Corp. v. Milgraum, 192 F.3d 1362 , 1366 (Fed.Cir.1999) (“[T]o the extent the embodiment in the patent achieves [the limitation], so does the [prior art].”) (alterations added).
Retrieving the full opinion text from the archive…
Mehl/biophile International Corp., Selvac Acquisitions Corp. And Nardo Zaias, m.d.,plaintiffs-appellants
v.
Sandy Milgraum, M.D., Palomar Medical Technologies, Inc., and Spectrum Medical Technologies, Inc.
99-1038.
Court of Appeals for the Federal Circuit.
Oct 27, 1999.
192 F.3d 1362

192 F.3d 1362 (Fed. Cir. 1999)

MEHL/BIOPHILE INTERNATIONAL CORP., SELVAC ACQUISITIONS CORP. and NARDO ZAIAS, M.D.,Plaintiffs-Appellants,
v.
SANDY MILGRAUM, M.D., PALOMAR MEDICAL TECHNOLOGIES, INC., and SPECTRUM MEDICAL TECHNOLOGIES, INC., Defendants-Appellees

99-1038

United States Court of Appeals for the Federal Circuit

DECIDED: September 30, 1999
Rehearing Denied October 27, 1999

Appealed from: United States District Court for the District of New Jersey Judge Alfred M. WolinJeffrey A. Schwab, Abelman, Frayne & Schwab, of New York, New York, argued for plaintiffs-appellants. With him on the brief were Michael Aschen and Anthony J. DiFilippi. Of counsel on the brief was George A. Arkwright, Schlesinger, Arkwright & Garvey, LLP, of Arlington, Virginia.

Wayne L. Stoner, Hale and Dorr, LLP, of Boston, Massachusetts, argued for defendants-appellees. With him on the brief were William F. Lee and James M. Hall. Of counsel on the brief was Thomas A. Reed, Palomar Medical Technologies, Inc., of Lexington, Massachusetts.

Before MAYER, MICHEL, and RADER, Circuit Judges.

RADER, Circuit Judge.

[*~1362]1

In this patent infringement action, MEHL/Biophile International Corp., Selvac Acquisitions Corp., and Dr. Nardo Zaias (collectively, MEHL/Biophile) asserted that Dr. Sandy Milgraum, Palomar Medical Technologies, Inc., and Spectrum Medical Technologies, Inc. (Milgraum) infringed U.S. Patent No. 5,059,192 (the '192 patent). On its motion for summary judgment, Milgraum contended that all of the '192 patent claims were anticipated by an instruction manual for the Spectrum RD-1200 laser and by a 1987 Journal of Investigative Dermatology article authored by Dr. Luigi Polla and others (the Polla article). The district court agreed that the manual anticipated the claims, granted summary judgment of invalidity, and dismissed the action. See MEHL/Biophile Int'l Corp. v. Milgraum, 8 F. Supp. 2d 434, 47 USPQ2d 1248 (D.N.J. 1998). Although this court disagrees that the manual discloses all the elements of the claimed invention, because the Polla article does, this court affirms.

I.

2

The '192 patent, entitled "Method of Hair Depilation," claims a method for removing hair using a laser. Hairs grows out of hair follicles, tubular apertures in the skin. The collection of germ cells from which hairs grow, known as the papilla, lies at the base of the follicle. The '192 patent claims a method for destroying the papilla,thereby preventing hair regrowth. The written description discloses the use of a Q-switched ruby laser to effect the destruction.

3

At a meeting of the American Academy of Dermatology, Dr. Zaias visited Spectrum's booth where Spectrum displayed such a laser, known as the RD-1200. Spectrum sold the RD-1200 for use in removing tattoos. Dr. Zaias recognized that the same principles that govern laser absorption in skin pigmented by a tattoo would also focus laser absorption on the natural skin pigment found in the papilla. More specifically, the papilla contains granules (called melanosomes) of a dark pigment (called melanin). A Q-switched ruby laser aimed at the hair follicle will penetrate the skin and reach the papillary melanin. At a particular wavelength, the laser will heat up and destroy the papilla without damaging surrounding tissue.

4

Claim 1 of the patent, the only independent claim, reads:

5

1. A method of hair depilation, comprising the steps of:

6

a) aligning a laser light applicator substantially vertically over a hair follicle opening, said applicator having an aperture of sufficient area to surround a hair follicle and overlie its papilla;

7

b) applying through said aperture to the hair follicle a pulse of laser energy of a wavelength which is readily absorbed by the melanin of the papilla and having a radiant exposure dose of sufficient energy and duration to damage its papilla so that hair regrowth is prevented and scarring of the surrounding skin is avoided.

8

Dependent claims 2-6 further specify parameters of the laser light applicator, energy delivery, and the type of laser.

[*~1363]9

MEHL/Biophile sued Milgraum in the United States District Court for the District of New Jersey for infringement of all the claims of the '192 patent. Milgraum moved for summary judgment of invalidity based on 35 U.S.C. § 102 (1994), arguing that two prior art references each teach all the limitations of the claims. As noted at the outset, Milgraum relied on the manual for the RD-1200 laser which describes the use of a laser to remove tattoos. The manual teaches the use of a Q-switched ruby laser to remove a tattoo: "[E]nergy is selectively absorbed only by pigmented chromophores and not surrounding tissue, greatly reducing the risk of scarring."

10

Milgraum also relied on the Polla article entitled "Melanosomes Are a Primary Target of Q-Switched Ruby Laser Irradiation in Guinea Pig Skin." The Polla article documents "the tissue damage induced by Q-switched ruby laser pulses in black, brown, and albino (control) guinea pigs . . . in an effort to define the nature and extent of pigmented cell injury." The method involves epilating guinea pigs with soft wax, holding the aperture of the laser in contact with the skin, and pulsing the laser. Using an electron microscope, the researchers observed "disruption of melanosomes deep in the hair papillae."

11

The district court considered both references, but ultimately rested its decision on the RD-1200 manual. MEHL/Biophile appeals. MEHL/Biophile makes several arguments for disregarding the manual as an anticipating reference. For instance, MEHL/Biophile argues that the manual does not teach use of the laser to remove hair at all. Further MEHL/Biophile contends that the manual does not disclose a substantially vertical alignment, a claim element. As for the Polla article, MEHL/Biophile argues that the reference relates to guinea pig skin and does not mention hair depilation. In addition, MEHL/Biophile contends that the epilation of the guinea pig backs removed the papilla so the laser treatment could not have damaged the papilla.

II.

[*~1364]12

This court reviews a district court's grant of summary judgment by reapplying the standard applicable at the district court. See Conroy v. Reebok Int'l, Ltd., 14 F.3d 1570, 1575, 29 USPQ2d 1373, 1377 (Fed. Cir. 1994). Summary judgment is appropriate only when "there is no genuine issue as to any material fact and . . . the moving party is entitled to a judgment as a matter of law." Fed. R. Civ. P. 56(c). In its review, this court draws all reasonable inferences in favor of the non-movant. See Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986).

13

"To anticipate a claim, a prior art reference must disclose every limitation of the claimed invention, either explicitly or inherently." In re Schreiber, 128 F.3d 1473, 1477, 44 USPQ2d 1429, 1431 (Fed. Cir. 1997). As this court's predecessor stated in In re Oelrich, 666 F.2d 578, 581, 212 USPQ 323, 326 (CCPA 1981) (quoting Hansgirg v. Kemmer, 102 F.2d 212, 214, 40 USPQ 665, 667 (CCPA 1939)) (internal citations omitted):

14

Inherency, however, may not be established by probabilities or possibilities. The mere fact that a certain thing may result from a given set of circumstances is not sufficient. If, however, the disclosure is sufficient to show that the natural result flowing from the operation as taught would result in the performance of the questioned function, it seems to be well settled that the disclosure should be regarded as sufficient.

[*~1365]15

Thus, a prior art reference may anticipate when the claim limitation or limitations not expressly found in that reference are nonetheless inherent in it. See In re Oelrich, 666 F.2d at 581; Verdegaal Bros., Inc. v. Union Oil Co. of Cal., 814 F.2d 628, 630, 2 USPQ2d 1051, 1053 (Fed. Cir. 1987). Under the principles of inherency, if the prior art necessarily functions in accordance with, or includes, the claimed limitations, it anticipates. See In re King, 801 F.2d 1324, 1326, 231 USPQ 136, 138 (Fed. Cir. 1986). Inherency is not necessarily coterminous with the knowledge of those of ordinary skill in the art. Artisans of ordinary skill may not recognize the inherent characteristics or functioning of the prior art. See id., 801 F.2d at 1326.

The RD-1200 Manual

16

The RD-1200 manual cannot anticipate because it does not teach all the limitations of the claimed invention. Claim 1 includes the step of "aligning a laser light applicator substantially vertically over a hair follicle opening." The parties agree that the manual does not discuss hair follicles, let alone aligning the laser over a hair follicle opening. Thus, the manual does not explicitly teach alignment substantially vertically over a follicle opening. Without explicit teachings of this claim limitation, this court must nonetheless examine whether such alignment is inherent in the manual's disclosure.

17

The manual teaches aiming the laser at skin pigmented with tattoo ink. The record discloses no necessary relationship between the location of a tattoo and the location of hair follicles. Therefore, an operator of the RD-1200 laser could use the laser according to the manual without necessarily aligning the laser "substantially vertically over a hair follicle opening." The possibility of such an alignment does not legally suffice to show anticipation. See In re Oelrich, 666 F.2d at 581. Occasional results are not inherent. Because this court holds that the manual does not inherently teach this limitation of the claimed invention, it does not address MEHL/Biophile's other arguments. To anticipate, a single reference must teach every limitation of the claimed invention. Without an inherent teaching about alignment, the manual does not anticipate the claimed invention.

The Polla Article

18

Although the district court did not reach the Polla article in its anticipation analysis, "[a]ppellees always have the right to assert alternative grounds for affirming the judgment that are supported by the record." Datascope Corp. v. SMEC, Inc., 879 F.2d 820, 822 n.1, 11 USPQ2d 1321, 1322 n.1 (Fed. Cir. 1989). Milgraum asserts that the Polla article constitutes such an alternative ground. This court agrees.

19

As to the "aligning" step, the Polla article does not suffer from the same deficiency as the manual. It is not a question of probabilities as to whether a person of ordinary skill following the teachings of the article will align the laser light applicator over a hair follicle. The researchers focused their study on the epilated backs of guinea pigs. No one disputes that guinea pigs have hairy backs. Indeed, the article itself is replete with references to the irradiation of hair follicles and resulting follicular damage:

20

At 0.8 J/cm2, epidermal lesions were more marked and involved hair follicles 0.3 mm below the skin surface . . . .

21

[L]esions were also present 0.5 mm deep in follicles.

22

[E]ven at the highest radiant exposure (1.2 J/cm2), brown [guinea pig] skin never showed full-thickness epidermalnecrosis and at 0.8 J/cm2, follicular damage was observed to a depth of 0.5 mm and at 1.2 J/cm2 to a depth of 0.7 mm below the skin surface.

23

. . . .

24

Follicular changes were similar in nature and extent to the epidermal alterations described above, and were associated with melanosome disruption.

25

. . . .

26

Specifically, we have shown that . . . pigmented structures in the deep dermis such as hair follicles are affected . . . .

27

The article further contains a photograph showing "[f]ollicular changes induced by ruby laser." The changes include disruption of "melanosomes contained within follicular epithelium." Moreover the article specifically mentioned disruption of the hair papillae:

28

At 0.8 and 1.2 J/cm2, individual melanosomes were more intensely damaged and disruption of melanosomes deep in the hair papillae was observed.

29

Finally, the method of exposing the Q-switched ruby laser to the guinea pig skin also inherently teaches substantially vertical alignment over hair follicle openings:

30

The collimated laser beam struck a circular aperture, 2.5 mm in diameter, held in contact with the skin of the animals.

31

The record shows that holding the collimated laser in contact with the skin would align it perpendicular to the skin surface and therefore substantially vertically over follicle openings. Viewed as a whole, this disclosure shows, in the words of In re Oelrich, 666 F.2d at 581, that the "natural result flowing from the operation as taught would result in" alignment of the laser light over a hair follicle, as claimed. No reasonable jury could find otherwise.

32

MEHL/Biophile's remaining arguments concerning the Polla article are unavailing. The Polla article concerns itself with guinea pig, rather than human, skin, but that difference is irrelevant to the anticipation analysis. Nothing in the claim limits the method's reach to human skin. Similarly, the Polla article's failure to mention hair depilation as a goal is similarly irrelevant. MEHL/Biophile does not dispute on appeal that the laser operating parameters disclosed in the article substantially coincide with those disclosed in the patent. Accordingly, to the extent the embodiment in the patent achieves hair depilation, so does the Polla method. Where, as here, the result is a necessary consequence of what was deliberately intended, it is of no import that the article's authors did not appreciate the results. See W.L. Gore & Assocs. v. Garlock, Inc., 721 F.2d 1540, 1548, 220 USPQ 303, 309 (Fed. Cir. 1983). Finally, as mentioned earlier, the article itself belies MEHL/Biophile's argument that the wax epilation prescribed by the article resulted in removal of the papilla.The article specifically states that "disruption of melanosomes deep in the hair papillae was observed." MEHL/Biophile's expert testimony contradicting the plain language of the reference does not create a genuine issue of fact.

33

Thus, the Polla article anticipates claim 1 of the '192 patent. Because MEHL/Biophile has not separately argued the validity of the dependent claims, the judgment of invalidity as to those claims also stands.

COSTS

[*~1366]34

Each party shall bear its own costs.

AFFIRMED